Progesterone containing oral dosage forms and kits

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9375437
APP PUB NO 20130029947A1
SERIAL NO

13644929

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides for progesterone containing pharmaceutical oral dosage forms, pharmaceutical kits, and related methods. In one embodiment, an oral dosage form formulated for on-going administration is provided. The oral dosage form includes an amount of progesterone and a pharmaceutically acceptable carrier. The oral dosage form is formulated such that upon single dose administration to a non-pregnant woman in follicular phase, the oral dosage form provides a serum progesterone C24h of at least 0.20 ng/mL.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • LIPOCINE INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Giliyar, Chandrashekar Salt Lake City, US 98 1872
Nachaegari, Satish Kumar Salt Lake City, US 46 546
Nachiappan, Chidambaram Sandy, US 30 764
Patel, Mahesh V Salt Lake City, US 171 9192
Venkateshwaran, Srinivasan Salt Lake City, US 88 3169

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 28, 2023
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 28, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00